Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotide
Giordano Savelli, Francesco Bertagna, Fabio Franco, Ludovica Dognini, Giovanni Bosio, Elena Migliorati, Carlo Rodella, Giorgio Biasiotto, Giovanni Bettinsoli, Chiara Minari, Alberto Zaniboni, Chiara FVolume:
118
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/cncr.26616
File:
PDF, 908 KB
english, 2012